GW Pharmaceuticals Plc/ US36197T1034 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | -USD | - | - |
Fundamentals
FY 2020 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -0.15 USD | 650.00% |
EPS Diluted: | -0.15 USD | 650.00% |
Revenues per Share: | - USD | - |
Book Value per Share: | - USD | - |
Cash Flow per Share: | - USD | - |
Dividend per Share: | 0.00 USD | - |
Total | in mill. | |
Revenues: | 527.20 USD | 69.35% |
Net Income: | -58.10 USD | 545.56% |
Operating Cash Flow: | -27.40 USD | - |
Cash and Cash Equivalents: | 486.80 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | - | - |
P/BV ratio: | - | - |
P/CF Ratio: | - | - |
PEG: | - | - |
Earnings Yield: | - | -0.13% |
Dividend Yield: | - | 0.00% |
Market Capitalization | ||
Market Capitalization: | - USD | - USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | 37.34 mill. USD |
Shares Outstanding: | 368.97 mill. |
Profitability
Gross Profit Margin: | 100.00% |
EBIT Margin: | -9.83% |
Net Profit Margin: | -11.02% |
Return on Equity: | -7.84% |
Return on Assets: | -6.18% |
Financial Strength
Liquidity I / Cash Ratio: | 304.63% |
Liquidity II / Quick Ratio: | 349.19% |
Liquidity III / Current Ratio: | 456.51% |
Debt / Equity Ratio: | 26.77% |
Dynam. Debt / Equity Ratio: | -724.09% |
Efficiency
Employees: | 1,161 |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | 454,091.30 USD |
Net Income / Employee: | -50,043.07 USD |
Total Assets / Employee: | 809,216.19 USD |
* Fiscal Year End: | 31/12/2020 |
Accounting Standard: | US GAAP |
Currency: | USD |